Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mayra Hernandez-Sanabria"'
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
Autor:
Li Li, Han Chen, David Marin, Yuanxin Xi, Qi Miao, Jiangxing Lv, Pinaki Prosad Banerjee, Hila Shaim, May Daher, Rafet Basar, Nobuhiko Imahashi, Juan Jimenez, Bingqian Hu, Rohtesh S. Mehta, Lucila Nassif Kerbauy, Mecit Kaplan, Mayela Mendt, Gonca Ozcan, Elif Gokdemir, Mayra Hernandez Sanabria, Ye Li, Ken Chen, Jing Wang, Luis Muniz-Feliciano, Wei-Li Zhao, Richard E. Champlin, Elizabeth J. Shpall, Katayoun Rezvani
Publikováno v:
Blood Advances, Vol 3, Iss 23, Pp 4117-4130 (2019)
Abstract: Natural killer (NK) cells are highly heterogeneous, with vast phenotypic and functional diversity at the single-cell level. They are involved in the innate immune response against malignant and virus-infected cells. To understand the effect
Externí odkaz:
https://doaj.org/article/2a7a56d202f04a7b9d59cab57a91513d
Autor:
Li Li, Martin Treder, Mark Foster, Lucila Kerbauy, Nancy Marin, Mecit Kaplan, Pinaki Banerjee, Melissa Berrien-Elliott, Michelle Becker-Hapak, Rafet Basar, Luciana Garcia Melo, Carly Neal, Ethan McClain, May Daher, Ana Karen Nunez Cortes, Sweta Desai, Francesca Wei Inng Lim, Mayela Carolina Mendt, Timothy Schappe, Hila Shaim, Mayra Hernandez Sanabria, Pamela Wong, Enli Liu, Sonny Ang, Rong Cai, Vandana Nandivada, Vakul Mohanty, Yifei Shen, Natalia Baran, Natalie Fowlkes, Ken Chen, Luis Muniz-Feliciano, Joachim Koch, Wolfgang Fischer, Oswaldo Keith Okamoto, Yago Nieto, Richard Champlin, Elizabeth Shpall, Todd Fehniger, Katy Rezvani
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/5b9f3404348e403bad3e294fdcc2c3ea
Autor:
Hila Shaim, Zeev Estrov, David Harris, Mayra Hernandez Sanabria, Zhiming Liu, Peter Ruvolo, Phillip A. Thompson, Alessandra Ferrajoli, May Daher, Jan Burger, Muharrem Muftuoglu, Nobuhiko Imahashi, Li Li, Enli Liu, Abdullah Saleh Alsuliman, Rafet Basar, Lucila Nassif Kerbauy, Catherine Sobieski, Elif Gokdemir, Kayo Kondo, William Wierda, Michael Keating, Elizabeth J. Shpall, Katayoun Rezvani
Publikováno v:
Frontiers in Immunology, Vol 8 (2018)
Chronic lymphocytic leukemia (CLL) cells possess regulatory functions comparable to those of normal B10 cells, a regulatory B cell subset that suppresses effector T-cell function through STAT3-mediated IL-10 production. However, the mechanisms govern
Externí odkaz:
https://doaj.org/article/e083fa30bf44444692ed076413c733b3
Autor:
Mark P. Foster, Rong Cai, Ana Karen Nunez Cortes, Yago Nieto, Vakul Mohanty, Melissa M. Berrien-Elliott, Sweta Desai, Joachim Koch, Michelle Becker-Hapak, Mecit Kaplan, Pamela Wong, May Daher, Natalie W. Fowlkes, Martin Treder, Luciana Garcia Melo, Wolfgang Fischer, Vandana Nandivada, Carly Neal, Luis Muniz-Feliciano, Li Li, Sonny Ang, Natalia Baran, Enli Liu, Elizabeth J. Shpall, Todd A. Fehniger, Yifei Shen, Richard E. Champlin, Ethan McClain, Mayela Mendt, Pinaki P. Banerjee, Francesca Lorraine Wei Inng Lim, Mayra Hernandez Sanabria, Oswaldo Keith Okamoto, Hila Shaim, Lucila Nassif Kerbauy, Katy Rezvani, Nancy D. Marin, Rafet Basar, Timothy Schappe, Ken Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Natural killer (NK) cells are a nascent cellular immunotherapy for hematologic malignancies. Target recognition of NK cell-resistant cancers remains a substantial barrier to broad application of NK cell therapy. One solution are bispecific
Autor:
Joy Gumin, Mayela Mendt, Jun Yu, Matthias Eyrich, May Daher, Jinzhuang Dou, David Marin, Mecit Kaplan, Sufang Li, Jian Hu, Ana Karen Nunez Cortes, Stephan Mielke, Gonca Ozcan, Nobuhiko Imahashi, Richard E. Champlin, Pinaki P. Banerjee, Junjun Lu, Ken Chen, Elif Gokdemir, Katayoun Rezvani, Amy B. Heimberger, Cynthia Kassab, Enli Liu, Yifei Shen, Dihua Yu, Rafet Basar, Sunil Acharya, Luis Muniz-Feliciano, Giulio Draetta, Elizabeth J. Shpall, Fang Wang, Vakul Mohanty, Li Li, Nadima Uprety, Konrad Gabrusiewicz, Mustafa H Bdiwi, Natalie W. Fowlkes, Qi Miao, Lucila Nassif Kerbauy, Abdullah Alsuliman, Jun Wei, Daniel Zamler, Emily Ensley, Frederick F. Lang, Mayra Hernandez Sanabria, Hila Shaim, April L. Gilbert
Glioblastoma, the most aggressive brain cancer, often recurs because glioblastoma stem cells (GSCs) are resistant to all standard therapies. Here, we show that patient-derived GSCs, but not normal astrocytes, are highly sensitive to lysis by healthy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799a66fd4d6aa0a2a7363957b001c9b1
https://doi.org/10.1101/2020.03.30.016667
https://doi.org/10.1101/2020.03.30.016667
Autor:
Enli Liu, Richard Skinner, Leiser Silva, David Marin, Mark A. Behlke, Elif Gokdemir, Vakul Mohanty, Ali Rezvan, Jing Wang, Gonca Ozcan, Nobuhiko Imahashi, Mollie S. Schubert, Junjun Lu, Yuanxin Xi, Natalia Baran, Vandana Nandivada, Duncan Mak, May Daher, Mayra Hernandez Sanabria, Marina Konopleva, Sunil Acharya, Rafet Basar, Shahram Kordasti, Pinaki P. Banerjee, Navin Varadarajan, Hila Shaim, Rolf Turk, Matthew S. McNeill, Natalie W. Fowlkes, Nadima Uprety, Mustafa Bdaiwi, Lorenzo Brunetti, Lucila Nassif Kerbauy, Mayela Mendt, Shangrong Lyu, Garrett R. Rettig, Ana Karen Nunez Cortes, Li Li, Sonny Ang, Xinhai Wan, Richard E. Champlin, Gavin Kurgan, Emily Ensley, Francesca Lorraine Wei Inng Lim, Mohsen Fathi, Heng Li, Mecit Kaplan, Nedyalko Petrov, Katayoun Rezvani, Yifei Shen, Luis Muniz-Feliciano, Elizabeth J. Shpall, Ken Chen, Ye Li
Immune checkpoint therapy has produced remarkable improvements in the outcome for certain cancers. To broaden the clinical impact of checkpoint targeting, we devised a strategy that couples targeting of the cytokine-inducible SH2-containing (CIS) pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f677e91c0a4f6f4d876e4ef1a0180b
https://doi.org/10.1101/2020.03.29.014472
https://doi.org/10.1101/2020.03.29.014472
Autor:
Richard E. Champlin, Gavin Kurgan, Luis Muniz-Feliciano, Nadima Uprety, Pinaki P. Banerjee, Elizabeth J. Shpall, Mustafa Bdaiwi, David Marin, Mark A. Behlke, Ana Karen Nunez Cortes, Sunil Acharya, Junjun Lu, Emily Ensley, Vandana Nandivada, Mayela Mendt, Li Li, Stephan Mielke, Sonny Ang, Enli Liu, Mayra Hernandez Sanabria, Rafet Basar, Rolf Turk, Alexander D. Kontoyiannis, Lorenzo Brunetti, Mecit Kaplan, May Daher, Garrett R. Rettig, Matthew S. McNeill, Lucila Nassif Kerbauy, Sufang Li, Abdullah Alsuliman, Ye Li, Elif Gokdemir, Natalie W. Fowlkes, Gonca Ozcan, Mollie S. Schubert, Michael C. Gundry, Katayoun Rezvani
Publikováno v:
Blood Adv
Virus-specific T cells have proven highly effective for the treatment of severe and drug-refractory infections after hematopoietic stem cell transplant (HSCT). However, the efficacy of these cells is hindered by the use of glucocorticoids, often give
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01c6d8db110db396438e1a7d629615f3
http://hdl.handle.net/11391/1475147
http://hdl.handle.net/11391/1475147
Autor:
Akhilesh Kumar Shakya, Mayra Hernandez-Sanabria, Rohan S.J. Ingrole, Ravi P. Arya, Harvinder S. Gill, Jasim Uddin, Silke Paust, Wenqian Tao, E. Bart Tarbet, Lynn Bimler, Brett L. Hurst
Publikováno v:
Antiviral Research. 141:62-72
The extracellular domain of influenza A ion channel membrane matrix protein 2 (M2e) is considered to be a potential candidate to develop a universal influenza A vaccine. However poor immunogenicity of M2e presents a significant roadblock. We have dev
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
Autor:
Wei Li Zhao, Rohtesh S. Mehta, Jing Wang, Ken Chen, Katayoun Rezvani, Han Chen, Pinaki P. Banerjee, Ye Li, Luis Muniz-Feliciano, Yuanxin Xi, Mecit Kaplan, Elizabeth J. Shpall, Mayra Hernandez Sanabria, Elif Gokdemir, Juan Jimenez, Qi Miao, Gonca Ozcan, Hila Shaim, Mayela Mendt, Nobuhiko Imahashi, Lucila Nassif Kerbauy, Jiangxing Lv, Rafet Basar, May Daher, David Marin, Li Li, Bingqian Hu, Richard E. Champlin
Publikováno v:
Blood advances. 3(23)
Natural killer (NK) cells are highly heterogeneous, with vast phenotypic and functional diversity at the single-cell level. They are involved in the innate immune response against malignant and virus-infected cells. To understand the effect of NK div
Autor:
Graham D. Hogg, Sumihito Togi, Michael D. Keller, Tram N. Cao, Sinisa Savic, Matthew Collin, Ivan K. Chinn, Levi B. Watkin, Asbjørg Stray-Pedersen, Gina M. Doody, Matthew A. Care, Justin T. Gunesch, Duy T. Le, Shalini N. Jhangiani, Donna M. Muzny, Jordan S. Orange, Emily M. Mace, James R. Lupski, Mayra Hernandez-Sanabria, Andrew J. Cant, Venetia Bigley, Michael A. Caligiuri, Sheetal Maisuria, Steven M. Holland, Zeynep Coban Akdemir, Eva P. Szymanski, Jansen B. Smith, Aharon G. Freud, Silke Paust, Laura S. Angelo, Keiko Ozato, Richard A. Gibbs, David F. LaRosa
Publikováno v:
The Journal of clinical investigation. 127(1)
Human NK cell deficiencies are rare yet result in severe and often fatal disease, particularly as a result of viral susceptibility. NK cells develop from hematopoietic stem cells, and few monogenic errors that specifically interrupt NK cell developme